HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study
... secondary to venous hypertension, venous leg
ulcers are increasingly common, are costly, and are ... Characterized as difficult to heal, many such
ulcers develop into chronic, nonresponsive wounds ... "Based on an estimated 2.5 million venous leg
ulcers in the United States alone and actual direct ...
Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain
... Treatment Decreases Risk of Developing GI
ulcers by Approximately 50 Percent--
--Data ... less NSAID-induced upper gastrointestinal (GI)
ulcers (gastric and/or duodenal ulcers) compared to ... but they also increase the risk of developing
ulcers in the stomach or intestine and the risk of ...
Cardium Announces Completion of Patient Recruitment in Phase 2b Clinical Trial of Excellarate(TM) for the Potential Treatment of Diabetic Foot Ulcers
... for the potential treatment of non-healing foot
ulcers in patients with type I or type II diabetes. ... 120 patients with lower extremity neuropathic
ulcers that were chronically non-healing despite ... patients enrolled in the study, the mean size of
ulcers at treatment was approximately 2.9 cm2 (range ...
AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
... dose aspirin-associated gastric and/or duodenal
ulcers in patients at risk.
AstraZeneca also ... the risk reduction in the occurrence of gastric
ulcers associated with continuous non-steroidal ... aspirin is associated with a risk of peptic
ulcers and gastrointestinal symptoms.(3B,3C) These ...
ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
... use of Altrazeal(TM) in treating diabetic foot
ulcers is detailed in a poster titled "Properties of a ... Powder Dressing in the treatment of four separate
ulcers in diabetic patients. The treatments were ... at All Country Podiatry in NY. Four cases of
ulcers present on heel, toe or ankle are shown and each ...
Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers
... placebo plus standard care, in healing venous leg
ulcers over a 12-week treatment period.
... 18 years of age and older with venous leg
ulcers of at least 6 week's, but not more than 24 months duration. The
ulcers must be between 2 cm2 and 12 cm2 in area at ...
New Study Using Combination of Bioengineered Skin and Stem Cells Shows Promise in Treatment of Non-Healing Wounds
... complication of scleroderma is the development of
ulcers on the patients' fingers and toes that are very ... skin were used to successfully treat skin
ulcers of three scleroderma patients and discussed how ... one patient who had painful and incurable finger
ulcers for many years remained healed and free of pain ...
MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series
... - particularly in non-healing venous leg
ulcers - continues to grow. This case series validates ... in these very difficult to heal leg ulcers. Leg
ulcers are very burdensome for patients and their ... in Dallas, April 26-29.
About venous leg
ulcers
Venous ...
OmegaGenesis Unveils Novel Nanotechnology Platform With Broad Biomedical Applications
... is Developing Therapies for Wounds, Diabetic Foot
ulcers and Hair Growth Using Nano-Materials with ... therapies for wound healing, diabetic foot
ulcers and hair growth are being developed by the ... in the treatment of wound healing, diabetic foot
ulcers and hair growth are underway. Clinical trials are ...
Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints
... upper gastrointestinal (gastric and/or
duodenal)
ulcers in patients with mild-to-moderate pain when ... taking NSAIDs experience gastrointestinal
ulcers and a greater
percent suffer from upper GI ... who develop
endoscopically diagnosed gastric
ulcers during the 24-week treatment period,
as compared ...
Derma Sciences' MEDIHONEY(TM) Proven to Speed Healing in Stalled Leg Ulcers
... leg ulcers. Physicians treat
over 4 million leg
ulcers in the US per year, at a cost exceeding ... controlled clinical trial,
looked at venous leg
ulcers that had been proven to be non-healing ... reported that MEDIHONEY is effective on stalled
ulcers of
various etiologies. The recently published ...
New Data Show High Frequency of Medical Claims for Gastrointestinal Events by Patients on Antiplatelet Therapy
... Review of Insurance Claims Tracked
ulcers and Bleeding Among 368,000 ... progression of coronary heart disease,
ulcers and bleeding can result
in patients not taking ... incidence
of upper gastrointestinal bleeding and
ulcers in patients who take CGT-2168
and aspirin ...
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Prevention of Diabetic Foot Infections
... for the
treatment of mildly infected diabetic
ulcers and as an adjunct to systemic
antibiotic therapy ... with bacterial
pathogens that can prevent
ulcers from healing. Many such wounds become
clinically ... prevention of infected diabetic foot
ulcers and CollaRx Bupivacaine
Implant for the ...
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Moderately Infected Diabetic Foot Ulcers
... with bacterial
pathogens that can prevent
ulcers from healing. A high proportion of such
wounds ... of
bacterial resistance. Furthermore, diabetic
ulcers are often associated
with vascular disease and ... for the
treatment of infected diabetic foot
ulcers and recent market research
independently ...
MacroChem Announces Presentation of Pexiganan Phase 3 Study Results for Topical Treatment of Diabetic Foot Infection
... number of
diabetic foot infections. Diabetic foot
ulcers are a major concern and
burden to the ... interventional strategies for diabetic foot
ulcers and amputation
prevention. Featuring a ... of which about 60% get infected.
Diabetic foot
ulcers generally result from the consequences of ...
Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
... patients with
lower extremity diabetic foot
ulcers to participate in the MATRIX clinical
research ... of foot ulceration. Over 850,000
chronic diabetic
ulcers are diagnosed in the U.S. each year. Patients with
non-healing
ulcers are more susceptible to infections that may lead ...
Associated Foot & Ankle Specialists Enrolling Patients With Chronic Diabetic Foot Ulcers for MATRIX Clinical Trial
... announced it is recruiting patients with foot
ulcers due to diabetes
to participate in the MATRIX ... of foot ulceration. Over 850,000
chronic diabetic
ulcers are diagnosed in the U.S. each year. Patients with
non-healing
ulcers are more susceptible to infections that may lead ...
Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Trial
... patients with
lower extremity diabetic foot
ulcers to participate in the MATRIX clinical
trial. The ... of foot ulceration. Over 850,000
chronic diabetic
ulcers are diagnosed in the U.S. each year. Patients with
non-healing
ulcers are more susceptible to infections that may lead ...
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers
... with bacterial
pathogens that can prevent
ulcers from healing. A high proportion of such
wounds ... of bacterial resistance. Furthermore, diabetic
ulcers are often
associated with vascular disease and ... for
the treatment of infected diabetic foot
ulcers and recent market research
independently ...
MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
... to treat infected diabetic foot
ulcers and that MacroChem is
dedicated to the ... foot infections in
the U.S. Diabetic foot
ulcers in the approximately 20 million diabetics in
the ... of which about 60% get
infected. Diabetic foot
ulcers generally result from the consequences ...
Innocoll Provides a Progress Update on its Clinical Development Programs and Specialty Pharmaceutical Operations
... for the treatment of infected diabetic
foot
ulcers and recent market research independently ... of painful
chronic and acute wounds, including
ulcers of various etiologies and burns.
Patients with ... and prevention of infected
diabetic foot
ulcers and Bupivacaine Implant for the management ...
Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers
... states Cathy
Bradshaw, President of Wound Care Innovations. Venous stasis
ulcers of the
lower extremity is a common problem among diabetic patients and ... costs to
the healthcare system. It has been estimated that venous
ulcers cause the
loss of approximately 2 million working days and incur treatment ...
Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
... the EU Tracleer(R) is also
indicated to reduce the number of new digital
ulcers in patients with
systemic sclerosis and ongoing digital ulcer disease. ... have been treated
with Tracleer(R).
About Tracleer(R) in Digital
ulcers (DU)
DUs are a manifestation of the underlying vasculopathy which is ...
Randomized Controlled Clinical Trial Shows Derma Sciences MEDIHONEY(TM) Eradicates MRSA From Chronic Venous Ulcers
... 108-patient randomized and controlled clinical trial,
looked at venous leg
ulcers that had been proven to be non-healing under
standard treatment ... Care, the research paper
"Bacteriological Changes in Sloughy Venous Leg
ulcers Treated with Manuka
Honey or Hydrogel: an RCT," was written by lead ...
AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
... usage section. (4) Lassen et al. Complicated and uncomplicated peptic
ulcers in a Danish county 1993-2002: a population-based cohort study. Am J ... therapy in the acute management of patients with bleeding peptic
ulcers in the USA and Canada: a cost-effectiveness analysis Aliment ...
Immunosyn Releases Wound Healing Photographs From the First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
... which has been
successfully completed in Europe for treatment of Diabetic
ulcers with
SF-1019.
(Photo: ... from Diabetic Mellitus such as Diabetic Neuropathy
(DN) and diabetic
ulcers (DU), auto-immune disorders such as Multiple
Sclerosis (MS) and ...
Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
... Gentamicin-Collagen
sponge for the treatment of infected diabetic foot
ulcers and our
Gentamicin Surgical Implant for the prevention of surgical site ... Topical for the treatment and prevention of infected diabetic
foot
ulcers and CollaRx Bupivacaine Implant for the management of
post-operative pain, ...
Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501
... demonstrated to significantly reduce the incidence of gastric and
duodenal
ulcers vs. placebo when administered together with NSAIDs. "This study is ... in the risk of development of ibuprofen-associated upper
gastrointestinal
ulcers in patients who require the use of ibuprofen. The
trials began in March ...
New Powder Speeds Healing of Difficult Foot Wounds
... )
This wound powder is especially promising for the nearly 24 million Americans diagnosed with diabetes. Diabetic foot
ulcers are the leading cause of non-traumatic, lower-limb amputations in the United States. In a recent APMA survey, 18 percent of people with diabetes ...
Current Status of the Development Programs of New Indications and Formulations for Aricept(R) for Enhancing Patient Value
... Aricept improves cognition and delays functional decline.
Aricept is well tolerated, but may not be for everyone. People at risk for stomach
ulcers or who take certain other medicines should tell their doctors because serious stomach problems, such as bleeding, may get worse. Some people who ...
Hand Washing with 4% CHG Antiseptic Kills Flu Viruses
... A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure
ulcers and increased home treatment.
...
Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
... endoscopies at baseline and on day seven. Subjects receiving LT-NS001 experienced statistically significantly fewer endoscopically confirmed gastric
ulcers compared to subjects receiving naproxen. The full results from this study will be presented at scientific meeting during the third quarter of 2009. ...
Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009
... infections involving the deeper soft tissue, including severe cellulitis and major abscesses. These infections may occur in patients with skin
ulcers or burns, as well as patients who have undergone surgery or experienced other kinds of trauma. These infections affect over one million patients in ...
Innocoll Announces Dosing of Last Patient in Second US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Colorectal Surgery Patients
... products in Innocoll's development pipeline include CollaRx Gentamicin Topical for the treatment and prevention of infected diabetic foot
ulcers and CollaRx Bupivacaine Implant for the management of post-operative pain, both of which are currently in Phase 2 development. For more information, ...
Innocoll Announces Dosing of Last Patient in US Phase 3 Clinical Trial to Investigate GENTAMICIN SURGICAL IMPLANT for Prevention of Surgical Site Infections in Cardiac Surgery Patients
... products in Innocoll's development pipeline include CollaRx Gentamicin Topical for the treatment and prevention of infected diabetic foot
ulcers and CollaRx Bupivacaine Implant for the management of post-operative pain, both of which are currently in Phase 2 development. For more information, ...
ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium
... dry eye syndrome from Senju Pharmaceuticals Co., Ltd., in November of 2004. Ecabet sodium is already marketed in Japan as an oral agent for gastric
ulcers and gastritis by Mitsubishi Tanabe Pharma Corporation (formerly Tanabe Seiyaku Co., Ltd.) as an originator of ecabet sodium.
Ecabet sodium ...
Durezol(TM) in the Treatment of Uveitis and Ganciclovir in the Treatment of Herpetic Keratitis: Studies of Treatments for Leading Causes of Blindness to Be Presented
... of recurrence each year. The risk of blindness
increases with the number and severity of recurrences, so prompt treatment
of herpetic epithelial
ulcers is imperative to limit scarring and other
more serious complications.
About Durezol
Durezol (difluprednate ophthalmic emulsion) 0.05% is a ...
Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use
... of Gastroenterology
and the American Heart Association today released consensus guidelines
outlining a stepwise approach for reducing the risk of
ulcers and
gastrointestinal (GI) bleeding among patients using nonsteroidal
anti-inflammatory drugs (NSAIDs) along with antiplatelet agents.
...
Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing
... enzymatic debriding agent
that contains 250 collagenase units per gram of white petrolatum USP. It is
indicated for debriding chronic dermal
ulcers (e.g., pressure ulcers,
vascular ulcers, and diabetic ulcers) and severely burned areas. The enzyme
collagenase is derived from the fermentation by ...
Cardium Reports on Second Quarter 2008 Highlights and Financial Results
... the study. The MATRIX
clinical trial is evaluating the safety and efficacy of Excellarate for the
potential treatment of non-healing diabetic foot
ulcers and is expected to
enroll up to approximately 210 patients at up to 40 U.S. sites. The study
has also been the focus of media attention in multiple ...